loadpatents
name:-0.028031826019287
name:-0.014510869979858
name:-0.011089086532593
Gazzard; Lewis Patent Filings

Gazzard; Lewis

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gazzard; Lewis.The latest application filed is for "tdo2 inhibitors".

Company Profile
9.13.24
  • Gazzard; Lewis - South San Francisco CA
  • GAZZARD; Lewis - Belmont CA
  • Gazzard; Lewis - Craigavon GB
  • Gazzard; Lewis - North Yorkshire GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
TDO2 Inhibitors
App 20220306635 - Lin; Xingyu ;   et al.
2022-09-29
Azaindoles As Inhibitors Of Hpk1
App 20210299110 - HEFFRON; Timothy ;   et al.
2021-09-30
Naphthyridines as inhibitors of HPK1
Grant 11,034,692 - Chan , et al. June 15, 2
2021-06-15
Isoquinolines As Inhibitors Of Hpk1
App 20210163417 - Chan; Bryan ;   et al.
2021-06-03
Azaindoles as inhibitors of HPK1
Grant 10,952,995 - Heffron , et al. March 23, 2
2021-03-23
TDO2 Inhibitors
Grant 10,800,780 - Lin , et al. October 13, 2
2020-10-13
Piperidine derivatives as inhibitors of ubiquitin specific protease 7
Grant 10,766,903 - O'Dowd , et al. Sep
2020-09-08
TDO2 and IDO1 Inhibitors
App 20200216456 - Pei; Zhonghua ;   et al.
2020-07-09
TDO2 and IDO1 Inhibitors
App 20200123163 - Pei; Zhonghua ;   et al.
2020-04-23
Azaindoles As Inhibitors Of Hpk1
App 20200000780 - HEFFRON; Timothy ;   et al.
2020-01-02
Naphthyridines as inhibitors of HPK1
Grant 10,407,424 - Chan , et al. Sept
2019-09-10
Piperidine Derivatives As Inhibitors Of Ubiquitin Specific Protease 7
App 20190256518 - O'DOWD; Colin ;   et al.
2019-08-22
TDO2 Inhibitors
App 20190016726 - Lin; Xingyu ;   et al.
2019-01-17
Serine/threonine kinase inhibitors
Grant 10,154,995 - Blake , et al. Dec
2018-12-18
Naphthyridines As Inhibitors Of Hpk1
App 20180282328 - Chan; Bryan ;   et al.
2018-10-04
Isoquinolines As Inhibitors Of Hpk1
App 20180282282 - Chan; Bryan ;   et al.
2018-10-04
Serine/threonine Kinase Inhibitors
App 20170348310 - Blake; James F. ;   et al.
2017-12-07
Serine/threonine kinase inhibitors
Grant 9,763,942 - Blake , et al. September 19, 2
2017-09-19
Serine/threonine kinase inhibitors
Grant 9,670,208 - Blake , et al. June 6, 2
2017-06-06
Serine/threonine Kinase Inhibitors
App 20160303126 - Blake; James F. ;   et al.
2016-10-20
Serine/threonine Kinase Inhibitors
App 20160304519 - Blake; James F. ;   et al.
2016-10-20
1,7-diazacarbazoles and methods of use
Grant 9,440,976 - Dyke , et al. September 13, 2
2016-09-13
Serine/threonine kinase inhibitors
Grant 9,388,171 - Blake , et al. July 12, 2
2016-07-12
1,7-diazacarbazoles And Methods Of Use
App 20150328195 - Dyke; Hazel Joan ;   et al.
2015-11-19
Substituted quinazolines as serine/threonine kinase inhibitors
Grant 9,187,462 - Blake , et al. November 17, 2
2015-11-17
Quinazoline Compounds As Serine/threonine Kinase Inhibitors
App 20150087664 - Blake; James F. ;   et al.
2015-03-26
Methods Of Use Of Diazacarbazoles For Treating Cancer
App 20150087630 - Chen; Huifen ;   et al.
2015-03-26
1,7-diazacarbazoles And Methods Of Use
App 20140171407 - Dyke; Hazel Joan ;   et al.
2014-06-19
Serine/threonine Kinase Inhibitors
App 20140066453 - Blake; Jim ;   et al.
2014-03-06
Inhibitors Of Iap
App 20120270886 - Koehler; Michael F. T. ;   et al.
2012-10-25
IAP inhibitors
Grant 8,247,557 - Koehler , et al. August 21, 2
2012-08-21
1,7-diazacarbazoles And Methods Of Use
App 20110183938 - Dyke; Hazel Joan ;   et al.
2011-07-28
Iap Inhibitors
App 20090221630 - Koehler; Michael F.T. ;   et al.
2009-09-03
Caspase Activated Prodrugs Therapy
App 20070104719 - Carter; Paul J. ;   et al.
2007-05-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed